English

ADEZA BIOMEDICAL CORP

EDGAR

Annual report (10-K) · filed 2007-03-15

10 filing records in this dataset, filed from 2005-03-29 to 2007-03-15. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 45.9 million USD 2006-12-31 Source
Exact value

45921000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

2.53 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Net income: 6000 USD · 2006-01-01 – 2006-03-31 Source
Net income: 537000 USD · 2006-04-01 – 2006-06-30 Source
Net income: 751000 USD · 2006-07-01 – 2006-09-30 Source
Net income: 2527000 USD · 2006-01-01 – 2006-12-31 Source
Net income: 1294000 USD · 2006-01-01 – 2006-09-30 Source

Operating cash flow

5.85 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: 604000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 3394000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 604000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 4206000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: 3394000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 5851000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: 4206000 USD · 2006-01-01 – 2006-09-30 Source

Capital expenditure

278 thousand USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Capital expenditure: 81000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 154000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 81000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 198000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 154000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 278000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 198000 USD · 2006-01-01 – 2006-09-30 Source

Free cash flow

5.57 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Operating cash flow: 604000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 3394000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 604000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: 4206000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: 3394000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: 5851000 USD · 2006-01-01 – 2006-12-31 Source
Operating cash flow: 4206000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 81000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 154000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 81000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 198000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 154000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 278000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 198000 USD · 2006-01-01 – 2006-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2007-03-15.

Financial data available through: 2006-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 5 of 11 periods available· newest 2006-12-31
Net income: 5 of 11 periods available· newest 2006-12-31
Operating cash flow: 5 of 11 periods available· newest 2006-12-31
Capital expenditure: 5 of 11 periods available· newest 2006-12-31
Total assets: 4 of 11 periods available· newest 2006-12-31
liabilities: No compatible figures in this window
Current assets: 4 of 11 periods available· newest 2006-12-31
Current liabilities: 4 of 11 periods available· newest 2006-12-31
Cash and cash equivalents: 5 of 11 periods available· newest 2006-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
-79.5%

Prior period

USD 12.33 million

2005-01-01 – 2005-12-31
Current period

USD 2.53 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

2527000 − 12328000 = -9801000 USD

12328000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
2527000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Year-over-year change in Net income: -9801000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 2527000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28208 Input fundies:NetIncome: 12328000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28208
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-25.1%

Prior period

USD 7.81 million

2005-01-01 – 2005-12-31
Current period

USD 5.85 million

2006-01-01 – 2006-12-31

Exact inputs and evidence

5851000 − 7811000 = -1960000 USD

7811000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
5851000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Year-over-year change in Operating cash flow: -1960000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5851000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 Input fundies:OperatingCashFlow: 7811000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+24.1%

Prior period

USD 224,000

2005-01-01 – 2005-12-31
Current period

USD 278,000

2006-01-01 – 2006-12-31

Exact inputs and evidence

278000 − 224000 = 54000 USD

224000 USD · 2005-01-01 – 2005-12-31
Inspect prior input Prior source
278000 USD · 2006-01-01 – 2006-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Year-over-year change in Capital expenditure: 54000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 278000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 Input fundies:CapitalExpenditure: 224000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 329,000 Exact value Exact value: -329000 USD 2002-01-01 – 2002-12-31: -329000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADEZA BIOMEDICAL CORP · 2002-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Net Income: -329000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -329000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-05-006256.txt#12957 The citation records this snapshot. The page link may show a newer release later.	−USD 3.91 million Exact value Exact value: -3908000 USD 2002-01-01 – 2002-12-31: -3908000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADEZA BIOMEDICAL CORP · 2002-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Operating Cash Flow: -3908000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3908000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-05-006256.txt#13278 The citation records this snapshot. The page link may show a newer release later.	USD 140,000 Exact value Exact value: 140000 USD 2002-01-01 – 2002-12-31: 140000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADEZA BIOMEDICAL CORP · 2002-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Capital Expenditure: 140000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 140000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-05-006256.txt#13349 The citation records this snapshot. The page link may show a newer release later.	−USD 4.05 million Calculation and evidence -3908000 − 140000 USD Exact free cash flow: -4048000 USD 2002-01-01 – 2002-12-31: -3908000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 140000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADEZA BIOMEDICAL CORP · 2002-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Free cash flow: -4048000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3908000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-05-006256.txt#13278 Input fundies:CapitalExpenditure: 140000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-05-006256.txt#13349 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	USD 3.24 million Exact value Exact value: 3235000 USD 2003-01-01 – 2003-12-31: 3235000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADEZA BIOMEDICAL CORP · 2003-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Net Income: 3235000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: 3235000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-06-005036.txt#14705 The citation records this snapshot. The page link may show a newer release later.	USD 5.51 million Exact value Exact value: 5512000 USD 2003-01-01 – 2003-12-31: 5512000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADEZA BIOMEDICAL CORP · 2003-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Operating Cash Flow: 5512000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5512000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-06-005036.txt#15067 The citation records this snapshot. The page link may show a newer release later.	USD 125,000 Exact value Exact value: 125000 USD 2003-01-01 – 2003-12-31: 125000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADEZA BIOMEDICAL CORP · 2003-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Capital Expenditure: 125000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 125000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-06-005036.txt#15138 The citation records this snapshot. The page link may show a newer release later.	USD 5.39 million Calculation and evidence 5512000 − 125000 USD Exact free cash flow: 5387000 USD 2003-01-01 – 2003-12-31: 5512000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 125000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADEZA BIOMEDICAL CORP · 2003-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Free cash flow: 5387000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5512000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-06-005036.txt#15067 Input fundies:CapitalExpenditure: 125000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-06-005036.txt#15138 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	USD 8.87 million Exact value Exact value: 8869000 USD 2004-01-01 – 2004-12-31: 8869000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADEZA BIOMEDICAL CORP · 2004-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Net Income: 8869000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 8869000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28208 The citation records this snapshot. The page link may show a newer release later.	USD 6.28 million Exact value Exact value: 6282000 USD 2004-01-01 – 2004-12-31: 6282000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADEZA BIOMEDICAL CORP · 2004-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Operating Cash Flow: 6282000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6282000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 The citation records this snapshot. The page link may show a newer release later.	USD 144,000 Exact value Exact value: 144000 USD 2004-01-01 – 2004-12-31: 144000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADEZA BIOMEDICAL CORP · 2004-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Capital Expenditure: 144000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 144000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 The citation records this snapshot. The page link may show a newer release later.	USD 6.14 million Calculation and evidence 6282000 − 144000 USD Exact free cash flow: 6138000 USD 2004-01-01 – 2004-12-31: 6282000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 144000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADEZA BIOMEDICAL CORP · 2004-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Free cash flow: 6138000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6282000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 Input fundies:CapitalExpenditure: 144000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 12.33 million Exact value Exact value: 12328000 USD 2005-01-01 – 2005-12-31: 12328000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADEZA BIOMEDICAL CORP · 2005-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Net Income: 12328000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 12328000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28208 The citation records this snapshot. The page link may show a newer release later.	USD 7.81 million Exact value Exact value: 7811000 USD 2005-01-01 – 2005-12-31: 7811000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADEZA BIOMEDICAL CORP · 2005-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Operating Cash Flow: 7811000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 7811000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 The citation records this snapshot. The page link may show a newer release later.	USD 224,000 Exact value Exact value: 224000 USD 2005-01-01 – 2005-12-31: 224000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADEZA BIOMEDICAL CORP · 2005-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Capital Expenditure: 224000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 224000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 The citation records this snapshot. The page link may show a newer release later.	USD 7.59 million Calculation and evidence 7811000 − 224000 USD Exact free cash flow: 7587000 USD 2005-01-01 – 2005-12-31: 7811000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 224000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADEZA BIOMEDICAL CORP · 2005-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Free cash flow: 7587000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 7811000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 Input fundies:CapitalExpenditure: 224000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 2.53 million Exact value Exact value: 2527000 USD 2006-01-01 – 2006-12-31: 2527000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Net Income: 2527000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2527000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28208 The citation records this snapshot. The page link may show a newer release later.	USD 5.85 million Exact value Exact value: 5851000 USD 2006-01-01 – 2006-12-31: 5851000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Operating Cash Flow: 5851000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5851000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 The citation records this snapshot. The page link may show a newer release later.	USD 278,000 Exact value Exact value: 278000 USD 2006-01-01 – 2006-12-31: 278000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Capital Expenditure: 278000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 278000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 The citation records this snapshot. The page link may show a newer release later.	USD 5.57 million Calculation and evidence 5851000 − 278000 USD Exact free cash flow: 5573000 USD 2006-01-01 – 2006-12-31: 5851000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 278000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · ADEZA BIOMEDICAL CORP · 2006-12-31 ADEZA BIOMEDICAL CORP (edgar:902482) Free cash flow: 5573000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-04T03:23:07Z Snapshot: bdaf1b2f24ca63150727caabdd54df8a33b0d53a18bdbb621ecd3b01f9d2e76a Dimensions: Consolidated View: https://fundies.io/companies/edgar/902482?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5851000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#28956 Input fundies:CapitalExpenditure: 278000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/902482/0000950134-07-005803.txt#29130 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

10 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0000902482, 902482, edgar:902482

ADEZA BIOMEDICAL CORP

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation